Skip Navigation
Find a Doctor
 
 
 
 

 

Photo of Dr. Michael McDevitt

Michael Anthony McDevitt, MD

Assistant Professor of Medicine
Male
Appointment Phone

410-955-3142

Main Location

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

View All Locations
Out-of-State & International Patients +
Out of State Patients

Call 410-464-6641 (8a.m. to 6p.m., EST, Mon-Fri)

Learn more about our out-of-state patient services »

International Patients

Call +1-410-502-0773 (7a.m. to 6p.m., EST, Mon-Fri)

Learn more about our international patient services »

Titles

  • Assistant Professor of Medicine
  • Assistant Professor of Oncology

Centers & Institutes

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Expertise

Acute Myeloid Leukemia, Anemias, Atypical Chronic Myeloid Leukemia (aCML), Chronic Myelomonocytic Leukemia, Medical Oncology, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasm (BCR-ABL Negative), Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Myelodysplastic/Myeloproliferative Neoplasms, Myeloproliferative Disorders, Primary Myelofibrosis, Secondary Myelofibrosis, Thrombocytopenias

Languages

  • English

Additional Resources

Additional Resources +
  • Education +

    Training

    • Cornell University Medical College (Ithaca NY) (1989)

    Residencies

    • Johns Hopkins University School of Medicine / Medicine (Baltimore MD) (1992)

    Fellowships

    • Boston Children's Hospital / Hematology (Boston MA) (1999)
    • Brigham and Women's Hospital / Hematology and Oncology (Boston MA) (1996)
  • Research & Publications +

    Research Summary

    Dr. McDevitt's research focuses on unraveling the acquired genetic and epigenetic changes that lead to poor prognosis myeloid disorders. The long term goals include:

    1. Identify underlying pathways of deregulation to ultimately allow effective therapeutic targeting.
    2. Develop more sensitive and accurate biomarkers that improve diagnostic classification and prognostication and can be used in translational clinical trials.
    3. Apply these findings in early phase clinical trials for patients with accelerating myeloproliferative disorders and mixed myelodysplastic syndrome/myeloproliferative disorders. Of particular current interest are DNA repair pathways and Parp inhibitors.

    Key collaborators include Judith Karp, Keith Pratz, James Herman, Alison Moliterno, Doug Smith, Hetty Carraway, Steve Gore, Cliff Takemoto, Scott Kaufmann (Mayo Clinic), and Jaroslaw Maciejewski (Cleveland Clinic).

    Selected Publications

    1. Jankowska AM, Makishima H, Tiu RV, Szpurka H, Huang Y, Traina F, Visconte V, Sugimoto Y, Prince C, O'Keefe C, Hsi ED, List A, Sekeres MA, Rao A, McDevitt MA, Maciejewski JP., Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2 and DNMT3A., Blood, 2011.
    2. Stein BL, Williams DM, O'Keefe C, Rogers O, Ingersoll RG, Spivak JL, Verma A, Maciejewski JP, McDevitt MA, Moliterno AR., Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes., Haematologica, 2011.
    3. Tiu RV, O'Keefe CL, Gondek LP, Huh J, Theil K, Mohamedali A, Advani AS, List A, Sekeres MA, McDevitt MA, Mufti G, Maciejewski JP, Prognostic impact of SNP array karyotyping in Myelodysplastic syndromes and related myeloid malignancies, BLOOD, 2011.
  • Academic Affiliations & Courses +
  • Activities & Honors +
  • Videos & Media +
  • Events +
  • Contact & Locations +

    Locations

    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    401 N. Broadway
    Baltimore, MD 21231
    Phone: 410-955-3142
    Appointment Phone: 410-955-3142
    Fax: 410-614-0854
    Location Map

    Department/Division

    • Medicine - Hematology

Is This You? Edit Profile

 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer